Budget impact analysis of the use of paricalcitol for the treatment of secondary hyperparathyroidism in chronic kidney disease. Farmeconomia. Health economics and therapeutic pathways, [S. l.], v. 15, n. 3, 2014. DOI: 10.7175/fe.v15i3.938. Disponível em: https://journals.seedstm.com/index.php/FE/article/view/938. Acesso em: 29 oct. 2025.